This is a paid press release. Contact the press release distributor directly with any inquiries.

Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Pharming Group N.V.

Tue, February 17, 2026 at 4:00 PM GMT+9 1 min read

In this article:

PHAR

+0.78%

PHGUF

-30.23%

Pharming Group N.V.

**Leiden, the ****Netherlands, February 17, 2026: **Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced its participation in the Oppenheimer 36th Annual Healthcare Life Sciences Conference being held virtually on February 25-26, 2026.

Fabrice Chouraqui, Chief Executive Officer, and Anurag Relan, M.D., Chief Medical Officer, will present on Wednesday, February 25 at 12:40pm ET/18:40 CET. A live webcast and replay of the presentation will be made available in the “Upcoming Events” and “News” sections of Pharming’s website.

To schedule a one-on-one meeting with Pharming’s management team, please contact Investor Relations at [email protected] or your Oppenheimer representative.

About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are developing and commercializing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, with a significant proportion of its employees based in the U.S.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:
Investor Relations
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: [email protected]

Media Relations
Global: Saskia Mehring, Corporate Communications Manager
T: +31 6 28 32 60 41
E: [email protected]

U.S.: Ethan Metelenis (Precision AQ on behalf of Pharming)
T: +1 (917) 882-9038

Netherlands: Leon Melens (LifeSpring Life Sciences Communication on behalf of Pharming)
T: +31 6 53 81 64 27

Attachment

Pharming to present at Oppenheimer Healthcare Life Sciences Conference_EN_17FEB2026

Terms and Privacy Policy

Privacy Dashboard

More Info